e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
New insights into lung disease pathogenesis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
B-cell activating factor: The architect of lymphoid follicles in severe COPD
Francesca Polverino (Brookline, United States of America), Francesca Polverino, Borja Cosio, Maria Laucho-Contreras, Jaime Pons, Amanda Iglesias, Andreas Jahn, Jaume Sauleda, Miguel Divo, Victor Pinto-Plata, Alvar Agusti, Bartolome Celli, Caroline Owen
Source:
International Congress 2015 – New insights into lung disease pathogenesis
Session:
New insights into lung disease pathogenesis
Session type:
Thematic Poster Session
Number:
883
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Francesca Polverino (Brookline, United States of America), Francesca Polverino, Borja Cosio, Maria Laucho-Contreras, Jaime Pons, Amanda Iglesias, Andreas Jahn, Jaume Sauleda, Miguel Divo, Victor Pinto-Plata, Alvar Agusti, Bartolome Celli, Caroline Owen. B-cell activating factor: The architect of lymphoid follicles in severe COPD. Eur Respir J 2015; 46: Suppl. 59, 883
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Definition and history of sarcoidosis
Related content which might interest you:
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Mapping of eosinophil and basophils in COPD lung tissues
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Blood T regulatory lymphocytes number is decreased in severe COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Evidence for cell mediated immune dysfunction in the COPD lung: The role of cytotoxic CD4+ T cells
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Antinuclear antibodies and rheumatoid factor are associated with blood eosinophils in asthma and COPD
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Imbalance of pro-inflammatory and anti-inflammatory markers on circulating dendritic cells in COPD
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Source: Eur Respir J 2009; 34: 219-230
Year: 2009
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
IgA expression in peribronchial and lung follicular B cells from COPD patients
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept